True Fighter for India

Date: 06/07/2013

Publication:

India Abroad

Aziz Haniffa profiles Amita Gupta, who is revolutionizing the understanding and treatment of a plethora of deadly diseases.

An exerpt…

Despite gargantuan challenges, why is she virtually obsessed with trying to make a difference in India? “India is where my family is from and where I have felt most connected to the people — to the public health needs,” she replied. “India is such a complex and dynamic place where almost every infectious disease in the textbooks exists, so there is so much to learn and so much to be done. It also is a place where there are smart people and opportunities to build infrastructure to study these infectious diseases. There is a clear, compelling public health need. And if solutions can be sought for India that are scalable and cost-effective there, they have great relevance to the rest of the world.”

Read the full article

Clinical Trials

A5279, Phase III Clinical Trial of Ultra-Short-Course...

This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...

Read More

P1070, Dose-Finding and Pharmacogenetic Study of Efavirenz...

Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...

Read More

P1077BF: Breastfeeding Version of the PROMISE Study...

1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

A5361s: Pitavastatin to REduce Physical Function Impairment...

A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...

Read More